Sun Pharma entered into an agreement with AstraZeneca
Sun Pharma entered into an agreement with AstraZeneca

Sun Pharma entered into an agreement with AstraZeneca

DSIJ Intelligence Article rating: 4.5

Sun Pharmaceutical Industries (Sun Pharma) announced that it has entered into a licensing agreement with AstraZeneca UK Ltd. (AstraZeneca) to introduce certain new ready to-use (RTU) infusion oncology products in China. These products will help in cancer treatments. The agreement will play a big role in bringing cost-effective and quality drugs to patients in China.

ICICI Lombard partners with Karur Vysya Bank
ICICI Lombard partners with Karur Vysya Bank

ICICI Lombard partners with Karur Vysya Bank

DSIJ Intelligence Article rating: 3.5

On Wednesday, ICICI Lombard announced a bancassurance tie-up with Karur Vysya Bank. The association will provide the bank’s customers an access to their insurer’s portfolio and make insurance more accessible to its customers across India.

Dixon to manufacture mobile phones for Samsung
Dixon to manufacture mobile phones for Samsung

Dixon to manufacture mobile phones for Samsung

DSIJ Intelligence Article rating: 2.9

Dixon Technologies and Samsung India Electronics, entered into an agreement for manufacturing Mobile Phones. Dixon will be manufacturing feature phones for Samsung from its new manufacturing facility located at Noida, Uttar Pradesh.

Q2 scorecard of Bandhan Bank
Q2 scorecard of Bandhan Bank

Q2 scorecard of Bandhan Bank

DSIJ Intelligence Article rating: 5.0
Bandhan Bank on Thursday announced its result for second quarter. The Net Profit of the bank rose by 99.18 per cent to Rs. 972 crore against Rs 488 crore in same quarter previous year. However, the numbers for this quarter are not comparable to the same quarter last year due to its merger with Gruh Finance. 

DSIJ MINDSHARE

Mkt Commentary4-Apr, 2025

Mindshare4-Apr, 2025

Mindshare4-Apr, 2025

Mindshare4-Apr, 2025

Mindshare4-Apr, 2025

Knowledge

General22-Mar, 2025

MF14-Mar, 2025

MF14-Mar, 2025

DALAL STREET INVESTMENT JOURNAL - DEMOCRATIZING WEALTH CREATION

Principal Officer: Mr. Shashikant Singh,
Email: principalofficer@dsij.in
Tel: (+91)-20-66663800

Compliance Officer: Mr. Rajesh Padode
Email: complianceofficer@dsij.in
Tel: (+91)-20-66663800

Grievance Officer: Mr. Rajesh Padode
Email: service@dsij.in
Tel: (+91)-20-66663800

Corresponding SEBI regional/local office address- SEBI Bhavan BKC, Plot No.C4-A, 'G' Block, Bandra-Kurla Complex, Bandra (East), Mumbai - 400051, Maharashtra.
Tel: +91-22-26449000 / 40459000 | Fax : +91-22-26449019-22 / 40459019-22 | E-mail : sebi@sebi.gov.in | Toll Free Investor Helpline: 1800 22 7575 | SEBI SCORES | SMARTODR